Hypnotic activity and effects on performance of lormetazepam and camazepam--analogues of temazepam.
1 The effects of lormetazepam and camazepam on sleep electroencephalography, visuo-motor coordination, digit symbol substitution and subjective assessments of mood and sleep quality were compared with placebo in six young adult males (18-27 years). The study was double blind. 2 Over the dose range 0.5, 1.0 and 2.0 mg, lormetazepam increased total sleep time (P less than 0.05), reduced wakefulness (P less than 0.05) and drowsy sleep (linear effect P less than 0.05). With 2.0 mg there were increases in stage 3 (P less than 0.05) and reduction in rapid eye movement sleep (P less than 0.01). Overnight ingestion of 2.0 mg, was followed by impaired visuo-motor coordination and fewer substitutions with the digit symbol test. 3 The hypnotic effect of 10-20 mg camazepam was limited to reduced awake activity (P less than 0.05), and with 20 mg there were increased substitutions on the digit symbol test. After 40 mg overnight stage 4 sleep was reduced (P less than 0.001) and performance at the digit symbol test was impaired (P less than 0.05 at 9.75 h). Morning ingestion of 20 mg camazepam did not alter performance, and the subjects assessed themselves to be more relaxed. 4 Lormetazepam is not specially indicated for those involved in skilled activity, but may prove useful for patients with insomnia resistant to other drugs. Camazepam would appear to be a promising anxiolytic with minimal effects on performance.
D000293:Adolescent; D000328:Adult; D014151:Anti-Anxiety Agents / Q000494:pharmacology*; D001569:Benzodiazepines; D003071:Cognition / Q000187:drug effects; D004644:Emotions / Q000187:drug effects; D006801:Humans; D006993:Hypnotics and Sedatives; D008140:Lorazepam / Q000031:analogs & derivatives / Q000494:pharmacology*; D008297:Male; D009048:Motor Skills / Q000187:drug effects*; D012890:Sleep / Q000187:drug effects; D012894:Sleep Stages / Q000187:drug effects; D013329:Structure-Activity Relationship; D013693:Temazepam / Q000031:analogs & derivatives / Q000494:pharmacology*
D014151:Anti-Anxiety Agents; D006993:Hypnotics and Sedatives; D001569:Benzodiazepines; D013693:Temazepam; C023842:lormetazepam; D008140:Lorazepam